The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Gregg Richard since 2015.
The trader's CIK number is 1619574.
At the time of the last reporting, Gregg Richard was the Chief Science Officer of Vitae Pharmaceuticals, Inc. (stock ticker symbol VTAE).
Also see all insider trading activities at Vitae Pharmaceuticals, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | VTAE | 0 | $0 | 0 | $0 | 123,902 | $1,050,688 |
| 2015 | VTAE | 0 | $0 | 0 | $0 | 100,557 | $478,478 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-10-19 | VTAE | Option Ex | 123,902 | 8.48 | 1,050,688 |
| 2015-11-13 | VTAE | Option Ex | 85,557 | 4.91 | 419,828 |
| 2015-11-16 | VTAE | Option Ex | 15,000 | 3.91 | 58,650 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gregg Richard (Chief Science Officer of Vitae Pharmaceuticals, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.